doi: 10.1016/j.metabol.2009.12.019 411 KitamiTFukudaSKatoTYamagutiKNakatomiYYamanoEet al
Thereby, considering its effects (5-7, 9,15-17), we advocate the stable gastric pentadecapeptide BPC 157 in both inflammatory bowel disease and multiple sclerosis therapy
Ante el " alarmante incremento del uso no aprobado de glutatin intravenoso como agente blanqueador", la agencia decidi en 2011 prohibirlo, segn explic entonces en una nota de prensa
Food and Drug Administration, voted 8-6 with one abstention to place BPC-157 on the Section 503A Bulk Drug Substances List
Anaemia is a condition where your body produces fewer red blood cells than normal or, in some cases, abnormal red blood cells, which cannot carry oxygen properly around your body